Ziegler Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-86,610
Closed -$996K 421
2023
Q1
$996K Buy
86,610
+815
+0.9% +$10.1K 0.04% 289
2022
Q4
$1.07M Buy
+85,795
New +$1.09M 0.04% 271
2021
Q4
Sell
-105,664
Closed -$1.55M 440
2021
Q3
$1.55M Buy
105,664
+15,928
+18% +$269K 0.06% 287
2021
Q2
$1.63M Buy
89,736
+40,493
+82% +$721K 0.05% 279
2021
Q1
$855K Sell
49,243
-1,307
-3% -$23K 0.03% 346
2020
Q4
$878K Sell
50,550
-6,584
-12% -$105K 0.03% 337
2020
Q3
$788K Sell
57,134
-1,579
-3% -$23.2K 0.03% 331
2020
Q2
$847K Sell
58,713
-27,060
-32% -$356K 0.03% 337
2020
Q1
$937K Buy
+85,773
New +$1.58M 0.03% 367

Other funds holding SBRA

Ziegler Capital Management's SBRA Position: Q2 2023 in Review

Ziegler Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q2 2023, closing a stake of 86,610 shares — an estimated $996K sold.

Ziegler Capital Management first reported a position in SBRA in Q1 2020 and held it in 9 quarters. The position peaked at $1.63M in Q2 2021. 325 funds tracked by Wall St. Rank hold SBRA as of Q2 2023.

  • Ziegler Capital Management reported no remaining Sabra Healthcare REIT position as of Q2 2023 after selling out during the quarter.
  • Ziegler Capital Management sold 86,610 Sabra Healthcare REIT shares in Q2 2023, an estimated $996K.
  • Ziegler Capital Management first reported a position in Sabra Healthcare REIT in Q1 2020 and held it in 9 quarters.
  • Ziegler Capital Management's Sabra Healthcare REIT position peaked at $1.63M in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2023.

Based on Ziegler Capital Management's 13F filing for Q2 2023, filed 25 Jul 2023.